We also have a Global and other country sites; click the links in 'Other AstraZeneca websites' for the directory. Beyond cancer research, our R&D will focus on cardiovascular and metabolic diseases, respiratory, inflammation and autoimmune diseases and conditions of the central nervous system. Full_time 199; Refine your search with a keyword Search AstraZeneca’s UK Marketing Company (UKMC) is a part of our global commercial organisation, and is responsible for the marketing of our medicines in the UK. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.AstraZeneca provides this link as a service to website visitors. Alderley Park is also home to employees within our global medicines development function, who are responsible for the late stage development of our pipeline (products in phase III development).
We publish information about the registration and results of all new and ongoing clinical trials for all products in all phases on our dedicated website. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. England 199; City. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. 1A Corp A1 Et. Additionally, we will have medicinal chemistry, high-throughput screening and cellular and molecular biology, as well as clinical development and pre-clinical research capabilities located on the site.Employing approximately 2,900 people, including some of the world’s most skilled and experienced science professionals, Alderley Park is renowned for the discovery and development of innovative new medicines. AstraZeneca is not responsible for the privacy policy of any third party websites. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.AstraZeneca provides this link as a service to website visitors.
Astrazeneca Uk Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as FULL The deal on the drug known as In September 2019, the company announced that it would cease drug production at its German headquarters in In October 2019, AstraZeneca announced it would sell the global commercial rights for its drug to treat acid reflux to German pharmaceutical company Cheplapharm Arzneimittel GmbH for as much as $276 million.In February 2020, AstraZeneca agreed to sublicense its global rights (except Europe, Canada and Israel) to the drug In June 2020, AstraZeneca Plc made a preliminary approach to rival drugmaker In July, the business entered into its second collaboration with In March 2020, the company announced that it would be donating In June 2020, further to making 100 million doses available to the UK's On 13 June 2020, AstraZeneca signed a contract with Europe’s Inclusive Vaccines Alliance, a group formed by France, Germany, Italy and the Netherlands, to supply up to 400 million doses of its experimental COVID-19 vaccine to all In August 2020, AstraZeneca agreed to provide 300 million doses to the U.S.A for $1.2 billion, implying a cost of $4 a dose. We encourage you to read the privacy policy of every website you visit.Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed. 2 Bucharest Business Park Sectorul 1 013681 Bucuresti Romania RO20 - SC Astrazeneca Pharma SRL Str. Fax +44 (0)1582 838 000. AstraZeneca’s response to the COVID-19 (novel coronavirus) outbreak is consistent with our values to follow the science, put patients first and do the right thing. ASTRAZENECA UK LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity We encourage you to read the privacy policy of every website you visit.Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed. Our purpose is to push the boundaries of science to deliver life-changing medicines. Adverse events should also be reported to AstraZeneca on 0800 783 0033 or via https://aereporting.astrazeneca.comThis website is intended for people seeking information on AstraZeneca's UK business. AstraZeneca è un’azienda biofarmaceutica che si impegna, su scala globale, nella ricerca, nello sviluppo e nella commercializzazione di farmaci etici. AstraZeneca has had a presence in the Gulf area since the early 1980s and has expanded over the years to be one of the top performing multinational companies in the region. ASTRAZENECA UK LIMITED was founded on 1998-11-26 and has its registered office in Cambridge. Cambridge 157; London 2; Macclesfield 19; Royston 15; Saffron Walden 1; Divisions. AstraZeneca is not responsible for the privacy policy of any third party websites. AstraZeneca is not responsible for the privacy policy of any third party websites. In 2013, it moved its headquarters to Cambridge, United Kingdom, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA (location of MedImmune) for work on biopharmaceuticals; and Mölndal (near Gothenburg) in Sweden, for research on traditional chemical drugs. Telephone +44 (0)1582 836 000. This website is intended for people seeking information on AstraZeneca's UK business.
Medical Information Direct Line. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. AstraZeneca India was established in 1979 and is headquartered at Bengaluru, Karnataka. AstraZeneca is committed to protecting the safety of patients who receive our products.Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.You are viewing AstraZeneca's India website is intended for people seeking information on AstraZeneca's business in India.